Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ian M. Ballard"'
Publikováno v:
Clinical Therapeutics. 17:602-612
This 4-week, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, multicenter study was designed to compare the efficacy and safety of etodolac and nabumetone in the treatment of patients with active osteoarthritis (OA) of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba9ed6da0fb4cbb1bea239c554df474e
https://doi.org/10.1016/0149-2918(95)80037-9
https://doi.org/10.1016/0149-2918(95)80037-9
Autor:
Gerard J. Bauhuis, Peter Mulder, Erik J. Haverkamp, John J. Schermer, Lee J. Nash, Dominic J. F. Fulgoni, Ian M. Ballard, Geoffrey Duggan, Andreas W. Bett, Robert D. McConnell, Gabriel Sala, Frank Dimroth
Publikováno v:
AIP Conference Proceedings.
The epitaxial lift‐off (ELO) technique has been combined with inverted III–V PV cell epitaxial growth with the aim of employing thin film PV cells in HCPV systems. In a stepwise approach to the realization of an inverted triple junction on a MELO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b8b2fdb8aa0234adbf15ac7194bd678
https://doi.org/10.1063/1.3509181
https://doi.org/10.1063/1.3509181
Autor:
Carsten Rohr, Keith W J Barnham, Nicholas Ekins-Daukes, James P Connolly, Ian M Ballard, Massimo Mazzer
Publikováno v:
US7868247, Internazionale, 2011
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::8ea1366658d870eede16e59c67d6d7e3
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=7868247.PN.&OS=PN/7868247&RS=PN/7868247
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=7868247.PN.&OS=PN/7868247&RS=PN/7868247
Publikováno v:
Journal of International Medical Research. 5:85-90
Mazindol is chemically unrelated to the phenethylamines and has not shown the side-effects or abuse potential of the amphetamine anorectics. To further define its potential for causing weight loss, a six-week double-blind placebo controlled study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a63db7a0c58d66f842b6d400f51036f
https://doi.org/10.1177/030006057700500202
https://doi.org/10.1177/030006057700500202
Autor:
Ian M. Ballard, Ellen M. Buerklin
Publikováno v:
Current Medical Research and Opinion. 6:90-96
SummarySeventy-four patients suffering from acute tendinitis/bursitis completed a double-blind trial to compare the effectiveness and tolerability of treatment with fentiazac with that of phenylbutazone. Patients received either 200 mg fentiazac or 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bc4b8b24daaa4ea28e5914b6aa48d6a
https://doi.org/10.1185/03007997909109516
https://doi.org/10.1185/03007997909109516
Publikováno v:
The Journal of international medical research. 7(1)
Preliminary clinical studies showed that oxaprozin (4,5 Diphenyl-2-oxazolepropionic acid) has anti-inflammatory and analgesic properties with a plasma half-life of about 40 hours. Consequently, a multicentre, double-blind parallel trial was conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eeec22987c88d3916daef9544e4d264
https://pubmed.ncbi.nlm.nih.gov/369925
https://pubmed.ncbi.nlm.nih.gov/369925